IPP Bureau
Granules' net zero commitment approved by SBTi
By IPP Bureau - November 28, 2024
In the near term, the company targets a 42% reduction in absolute Scope 1 and 2 emissions and Scope 3 emissions by FY2030
Fredun Pharmaceuticals to launch advanced functional foods plant
By IPP Bureau - November 28, 2024
The new facility marks a significant milestone for Fredun Pharmaceuticals as it expands its footprint in the rapidly growing pet care industry in India
Shilpa Medicare’s JV Oncosol gets USFDA approval for IMKELDI
By IPP Bureau - November 28, 2024
IMKELDI is an advanced liquid formulation of imatinib designed to provide dosing accuracy
Senores Pharmaceuticals launches Ivermectin Tablets in US with Dr. Reddy's Laboratories
By IPP Bureau - November 28, 2024
The product will be marketed by Dr. Reddy's
FDA approves BridgeBio’s Attruby for ATTR-CM treatment
By IPP Bureau - November 26, 2024
Attruby is the first and only approved product with a label specifying near-complete stabilization of TTR
Edwards’ SAPIEN 3 Ultra RESILIA Valve demonstrates positive outcome
By IPP Bureau - November 26, 2024
CAHO and Orchid Pharma partnership kicks off with conference on antimicrobial resistance
By IPP Bureau - November 26, 2024
This strategic alliance is aimed at strengthening hospital systems and developing advanced AMR interventions
Jackson ImmunoResearch launches new antibodies and conjugates
By IPP Bureau - November 26, 2024
GFP is a common fusion protein tag that enables protein expression to be monitored, quantified, and localized within the complex environment of the cell
Merck Life Science India signs MoU with DPIIT
By IPP Bureau - November 26, 2024
The initiative will encourage and motivate emerging biotech startups, innovators and entrepreneurs
Boehringer Ingelheim launches next generation poultry vaccine in India
By IPP Bureau - November 26, 2024
This is recommended for in-ovo vaccination of 18 to 19-day-old embryonated chicken eggs and one-day old chickens to protect against the virulent Marek’s disease
Merck announces pivotal phase 3 ZENITH trial evaluating WINREVAIR
By IPP Bureau - November 26, 2024
WINREVAIR met primary endpoint of time to first morbidity or mortality event for the treatment of patients with pulmonary arterial hypertension (PAH) functional class III or IV at high risk of mortality
Lonza announces first GMP batch completion at next-generation mammalian manufacturing facility in US
By IPP Bureau - November 25, 2024
First GMP batch released at Lonza’s next-generation mammalian manufacturing facility in Portsmouth (US)
Surendralal Karsanbhai elected to Merck Board of Directors
By IPP Bureau - November 25, 2024
With the addition of Karsanbhai, the Merck board will consist of 13 members
.jpg "Sourav Ganguly launches Beurer India's GL 22 Blood Glucose Monitor")
Sourav Ganguly launches Beurer India's GL 22 Blood Glucose Monitor
By IPP Bureau - November 25, 2024
The GL 22 Blood Glucose Monitor combines German precision with advanced technology designed to meet local needs
